• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Tuesday, May 30, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

BIAL Award in Biomedicine distinguishes research which is the basis of two of the vaccines against covid-19

Bioengineer by Bioengineer
February 18, 2022
in Science News
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A team led by American scientist Drew Weissman won the second edition of the BIAL Award in Biomedicine with a work focused on mRNA technology, which is now used in the Pfizer-BioNTech and Moderna vaccines to prevent COVID-19.

BIAL Award in Biomedicine 2021

Credit: BIAL Foundation

A team led by American scientist Drew Weissman won the second edition of the BIAL Award in Biomedicine with a work focused on mRNA technology, which is now used in the Pfizer-BioNTech and Moderna vaccines to prevent COVID-19.

The award, promoted by the BIAL Foundation, is worth 300,000 Euros and aims to distinguish a work in biomedicine of exceptional quality and scientific relevance.

The BIAL Award in Biomedicine 2021 was delivered in a ceremony held at the Rectory of the University of Lisbon on 18 February, and was attended by the President of the Republic, Marcelo Rebelo de Sousa, who chaired the session, the President of the BIAL Foundation, Luís Portela, jury member Menno Witter and award-wining authors Drew Weissman and Michael J. Hogan.

An important breakthrough of this technology for vaccine creation was published in 2017, even before the pandemic, in the research report “Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination”, published in Nature. The research report describes the complex work to engineer an mRNA vaccine to treat a disease and demonstrates its efficacy in mice and in monkeys.

The BIAL Award in Biomedicine 2021 distinguishes the work of Weissman and 36 other co-authors, researchers from the Universities of Pennsylvania, Duke and Kansas State (USA), Harvard Medical School (USA), National Institutes of Health (USA), Bioqual Inc. (USA), Acuitas Therapeutics (Canada) and BioNTech RNA Pharmaceuticals (Germany) at the time of publication of the research report.

The pandemic caused by SARS-CoV-2 has accelerated research in this area, but this work paves the way for a new generation of vaccines with the potential to revolutionize the treatment of a large number of diseases.

While traditional vaccines often use a modified virus to provoke a reaction in the immune system, the technology investigated by the BIAL Award in Biomedicine winning team uses a synthetic mRNA to allow the body to prepare itself against the disease. To do so, it uses an mRNA that makes the body’s own cells synthesize a viral protein that stimulates the body’s immune response.

Neuroscientist Ralph Adolphs, president of the jury of the BIAL Award in Biomedicine, considers that “this work represents an extraordinary achievement. It is a tour de force in molecular biology aimed at human health, and achieved the technological leap in mRNA vaccines that is the basis for the vaccines currently administered against SARS-CoV-2 to deal with the COVID pandemic in countries around the world”. 

Adolphs emphasizes that “there is now substantial evidence that mRNA technology has enormous applications: in addition to being used to deal with the current pandemic, mRNA vaccines are also being developed for infectious diseases such as malaria and influenza, and also for non-infectious diseases such as cancer“.

The winning work was chosen from 47 papers nominated among the most important research reports in the last 10 years in biomedicine. Applications included basic research studies, clinical trials, work in neurodegenerative disorders, cancer, and infectious diseases.

The next edition of the BIAL Award in Biomedicine, promoted by the BIAL Foundation, will take place in 2023.

 

Authors of the award-winning work and their institutions at the time of publication of the research report:

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, USA

Norbert Pardi, Michael J. Hogan, Hiromi Muramatsu, Veronica M. Holmes & Drew Weissman

Viral Pathogenesis Section, National Institute of Allergy and Infectious Disease, National Institutes of Health, USA

Rebecca S. Pelc, Christina R. DeMaso, Kimberly A. Dowd & Theodore C. Pierson

Bioqual Inc., Rockville, USA

Hanne Andersen, Wendeline Wagner, Alex Granados, Jack Greenhouse, Michelle Walker & Mark G. Lewis

Duke Human Vaccine Institute, Duke University School of Medicine, USA

Laura L. Sutherland, Richard M. Scearce, Robert Parks, Jae-Sung Yu, Charles E. McGee, Gregory D. Sempowski & Barton F. Haynes

Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, USA

Elinor Willis & Scott E. Hensley

Acuitas Therapeutics, Vancouver, Canada

Barbara L. Mui, Ying K. Tam, Thomas D. Madden & Michael J. Hope

Diagnostic Medicine and Pathobiology, College of Veterinary Medicine and the Biosecurity Research Institute, Kansas State University, USA

Yan-Jang Huang, Dana Vanlandingham & Stephen Higgs

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, USA

Harikrishnan Balachandran, Sujata Sahu, Michelle Lifton & Sampa Santra

BioNTech RNA Pharmaceuticals, Germany

Katalin Karikó

Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, USA

Barney S. Graham

 

 

 



DOI

10.1038/nature21428

Share12Tweet8Share2ShareShareShare2

Related Posts

Obstructive sleep apnea disrupts gene activity throughout the day in mice

Obstructive sleep apnea disrupts gene activity throughout the day in mice

May 30, 2023
michael HIV vaccine

Researchers use ‘natural’ system to identify proteins most useful for developing an effective HIV vaccine

May 30, 2023

Scientists identify how some angiogenic drugs used to treat cancer and heart disease cause vascular disease

May 30, 2023

CSI Singapore researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

May 30, 2023

POPULAR NEWS

  • plants

    Plants remove cancer causing toxins from air

    39 shares
    Share 16 Tweet 10
  • Element creation in the lab deepens understanding of surface explosions on neutron stars

    36 shares
    Share 14 Tweet 9
  • Groundbreaking study uncovers first evidence of long-term directionality in the origination of human mutation, fundamentally challenging Neo-Darwinism

    115 shares
    Share 46 Tweet 29
  • How life and geology worked together to forge Earth’s nutrient rich crust

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Obstructive sleep apnea disrupts gene activity throughout the day in mice

Researchers use ‘natural’ system to identify proteins most useful for developing an effective HIV vaccine

Scientists identify how some angiogenic drugs used to treat cancer and heart disease cause vascular disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 50 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In